<?xml version="1.0" encoding="UTF-8"?>
<p id="par0115" class="p">Results in (
 <xref rid="tbl0020" ref-type="table" class="xref">Table 4</xref>) showed that BPA treatment increased (
 <italic class="italic">P </italic>≤ 0.05) the mean values of MNPCEs significantly compared to control. In contrary, oral administration of PSO through the three regimens of treatment decreased significantly (
 <italic class="italic">P </italic>≤ 0.05) the mean value of MNPCEs in bone marrow cells. In addition, cytotoxicity evaluation of bone marrow erythrocytes showed that BPA induced significant reduction (
 <italic class="italic">P </italic>≤ 0.05) in the ratio of PCE/NCE as compared to control. Whereas, PSO through the three regimens of treatment has protection against BPA cytotoxicity. This protection was appeared in the elevation of the PCEs/NCEs ratio as compared with those of BPA treated group.
</p>
